Symptom burden among patients with Renal Cell Carcinoma (RCC): content for a symptom index

Por Harding, Gale, Cella, David, Robinson, Don, Mahadevia, Parthiv J, Clark, Jason, Revicki, Dennis A
Publicado em 2007

Content Development for the Functional Assessment of Cancer Therapy-Multiple Myeloma (FACT-MM): Use of Qualitative and Quantitative Methods for Scale Construction

Por Wagner, Lynne, Robinson, Don, Weiss, Matthias, Katz, Michael, Greipp, Phillip, Fonseca, Rafael, Cella, David
Publicado em 2012

The influence of baseline characteristics and disease stage on health‐related quality of life in multiple myeloma: findings from six randomized controlled trials

Por Robinson, Don, Esseltine, Dixie‐Lee, Regnault, Antoine, Meunier, Juliette, Liu, Kevin, van de Velde, Helgi
Publicado no Br J Haematol (2016)

A Comparison of the Renal Cell Carcinoma Symptom Index (RCC-SI) and the Functional Assessment of Cancer Therapy –Kidney Symptom Index (FKSI)

Por Rao, Deepa, Butt, Zeeshan, Rosenbloom, Sarah, Robinson, Don, Von Roenn, Jamie, Kuzel, Timothy M., Cella, David
Publicado em 2009

Bortezomib, thalidomide and dexamethasone, with or without cyclophosphamide, for patients with previously untreated multiple myeloma: 5‐year follow‐up

Por Ludwig, Heinz, Greil, Richard, Masszi, Tamas, Spicka, Ivan, Shpilberg, Ofer, Hajek, Roman, Dmoszynska, Anna, Paiva, Bruno, Vidriales, María‐Belén, Esteves, Graca, Stoppa, Anne Marie, Robinson, Don, Chaturvedi, Shalini, Ataman, Ozlem, Enny, Christopher, Feng, Huaibao, van de Velde, Helgi, Viterbo, Luisa
Publicado no Br J Haematol (2015)